EDIT

1.6602.92%
GM

George McDonald Church

Co-Founder & Scientific Advisory Board Member

Dr. George McDonald Church, Ph.D., is Co-Founder of TENZA, INC. and also serves as Director. He serves as Robert Winthrope Professor of Genetics, Molecular and Genetic Engineering at Harvard Medical School, as Venture Partner at Catalio Capital Management, LP, and as General Partner at Kendall Capital Partners, LP. He is Co-Founder of AdoraPet Biosciences, Inc. since August 15, 2022, Manifold Biotechnologies, Inc. since 2020, Veritas Genetics International Ltd., which he joined in 2014, Editas Medicine, Inc., which he joined in 2013, REG Life Sciences, LLC. since 2005, Alacris Pharmaceuticals, Knome, ReadCoor, Veritas Genetics, GlottaTech, Nebula Genomics, EnEvolv, Gen9, Tierra Biosciences, AbVitro, Egenesis Bio, Fitbiomics, Warp Drive Biosynthetics, Codon Devices, LS9, Pathogenica, Telome, Kern Systems Inc., Colossal Biosciences Inc., and Breaking, Inc. He is Founder of 64-x, Inc., where he also serves as Director and as Member of its Scientific Advisory Board, which he joined in August 2017. He is Founder of AbVitro LLC and also serves as Member of its Scientific Advisory Board. He is Founder of JURA Bio, Inc. and also serves as its Scientific Advisory Board Chair. He serves as Co-Founder and Director of Nabla Bio, Inc. He serves as Co-Founder and Member of Scientific Advisory Board of GRO Biosciences, where he is also Chair of Scientific Advisory Board, of EnPlusOne Biosciences Inc., where he is also Member of Scientific Advisory Board, of Rejuvenatebio, where he is also Member of Scientific Advisory Board, and of eGenesis, Inc. He serves as Co-Founder, Scientific Advisor, and Director of GC Therapeutics, Inc. He serves as Scientific Co-Founder and Member of Scientific Strategy Board at Inari, where he is also Scientific Co-Founder. He serves as Scientific Co-Founder and Member of Scientific Advisory Board at Dyno Tx. He serves as Chairperson of Gene Editing Advisory Board and Member of Scientific Advisory Board of NeuBase Therapeutics, Inc. since May 2023. He serves as Member of Advisory Board of Unravel Biosciences, Inc. since September 2023, Pattern Computer, Inc. since September 2021, Genscript Biotech Corporation since September 2019, GenScript Corporation since 2019, Solve, Inc. since June 23, 2016, Pupil Bio, Inc., Helix Nanotechnologies, Inc., VERITAS INTERCONTINENTAL, SL, BGI Tech Solutions Co., Ltd., and Frontier Bio Corporation. He serves as Chairman of Gene Therapy Scientific Advisory Board of Poseida Therapeutics, Inc. since July 2022. He serves as Member of Scientific Advisory Board of Roswell Biotechnologies, Inc. since October 2021, AOBiome, LLC. since May 2014, FUJIFILM Cellular Dynamics, Inc. since August 2009, Gnubiotics Sciences SA, Humanity Inc., Peptilogics, Inc., Genomatica, Inc., Complete Genomics, Inc., Intelligent Bio-Systems, Inc., Genia Technologies, Inc., Recombinetics, Inc., uBiome, Inc., Parabase Genomics, Inc., BioViva USA Inc., Ontera Inc., Singlera Genomics Inc., GenEdit Inc., NuProbe, Inc., Orbit Genomics, Inc., SNIPR Biome ApS, Aanika Biosciences, Inc., Ion Torrent Systems Incorporated, Shape Therapeutics Inc., Transposon Therapeutics, Inc., Tessera Therapeutics, Inc., Acuity Spatial Genomics, Inc., Gameto, Inc., Kanvas Biosciences, Inc., Breeze Bio, Inc., Celestial Therapeutics, Inc., and Cultivarium, LLC. He serves as Member of Scientific and Business Advisory Board of Viome Life Sciences, Inc. since March 2021. He serves as Co-Founder and Chairman of Medical and Scientific Advisory Board of Veritas Genetics International Ltd. He serves as Co-Founder and Chairman of Scientific Advisory Board of Tafkak, Inc., which he joined in 2007. He serves as Co-Founder and Scientific Advisory Board Member of Editas Medicine, Inc. He serves as Co-founder and Chairman of Advisory Board of Nebula Genomics, Inc. He serves as Adjunct Partner Board of IndieBio since September 2019. He serves as Independent Director of Sigma-Aldrich Corporation since October 2009. He serves as Director of Sigma-Aldrich Company Ltd. He serves as Technical Advisor of Joule Unlimited, Inc. He serves as Member of the Board of Advisors of Halcyon Molecular, Inc. He serves as Chairman of Scientific Advisory Board of Enzymatics Inc. He is Advisor of Biophysical Therapeutics, Inc., GnuBIO, Inc., Noblegen Biosciences, Inc., Rose Ventures, Inc., Social Impact Capital, and Boutique Venture Partners. He serves as Scientific Advisor of Centers for Age Control Inc. He serves as Member of Scientific and Medical Advisory Board of Novos Labs. He serves as Scientific Advisory Board Member of Integra Therapeutics SL. He serves as Member of Advisory Board of Form Bio, Inc. Dr. Church served as Chief Scientist of Lila Sciences, Inc. from March 2025 to March 2026. He served as Member of Scientific Advisory Board of Seres Therapeutics, Inc., Helicos BioSciences Corporation, Receptor BioLogix, Inc., GenapSys, Inc., Pathway Genomics Corporation from February 27, 2014, 23andMe Holding Co., and Seed Health, Inc. He served as Co-Founder of Codon Devices, Inc. from 2004. He was Medical Advisor of DNA Direct, Inc. He was Co-Founder, Director and Member of Scientific Advisory Board of Gen9, Inc. He was Co-Founder and Chief Science Advisor of enEvolv, Inc. from 2011. He was Co-Founder, SAB Chairman and Inventor of ReadCoor, Inc. He was Scientific Advisor of BioLoomics, Inc. At 64-x, Inc., he served as Founder, Director and Scientific Advisor from 2019 and as Co-Founder and Director until 2019. At Manifold Biotechnologies, Inc., he served as Co-Founder and Scientific Advisor until 2020. At Fitbiomics, he served as Co-Founder and Science Advisor until December 2022. At NeuBase Therapeutics, Inc., he served as Member of Scientific Advisory Board until May 2023. At Inari, he served as Member of Scientific Strategy Board. At Social Impact Capital, he served as Advisor. He was Adjunct Partner Board of IndieBio from September 2019. Dr. Church holds a Doctor of Philosophy degree in Biochemistry and Molecular Biology from Harvard University, earned in 1984, and a Bachelor of Arts degree in Zoology and Chemistry from Duke University.

Positions